Trial intelligence / Profile preview

Sevoflurane versus propofol sedation in cardiopulmonary bypass heart surgery

ChiCTR1800019106Phase 4Recruiting

Sponsor
Affiliated Hospital of Guizhou Medical University
Start
Nov 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of sevoflurane and propofol in acute lung injury (ALI) (2 arms), sponsored by Affiliated Hospital of Guizhou Medical University. Primary endpoints: Oxygenation index and Glycocalyx. Started Nov 2018; status: recruiting.

02

Drugs

sevofluranepropofol
03

Conditions

acute lung injury (ALI)

Beyond the preview

Go deeper on ChiCTR1800019106.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800019106.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call